Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04396197 |
Recruitment Status :
Completed
First Posted : May 20, 2020
Last Update Posted : May 20, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
COVID-19 Critical Illness Ards ICU Acquired Weakness | Other: Physiotherapy |
Study Type : | Observational |
Actual Enrollment : | 92 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care Requiring Invasive Ventilation: An Observational Study |
Actual Study Start Date : | March 1, 2020 |
Actual Primary Completion Date : | May 8, 2020 |
Actual Study Completion Date : | May 8, 2020 |

Group/Cohort | Intervention/treatment |
---|---|
COVID-19
Observations taken of standard physiotherapy practice. All patients are assessed daily and receive respiratory care and rehabilitation as deemed appropriate by the treating therapist
|
Other: Physiotherapy
Daily physiotherapy to include respiratory care and rehabilitation based on the individual therapists clinical reasoning
Other Name: Rehabilitation |
- Mobility level [ Time Frame: At ICU discharge, an average of 3 weeks ]Highest level of mobility achieved at the point of ICU discharge
- Time taken to first mobilise [ Time Frame: during ICU admission, up to 3 weeks ]Time taken to first mobilise, defined as sitting on the edge of the bed or higher
- Discharge location [ Time Frame: Hospital discharge, up to 2 months ]Discharged to home, home with rehab, or a community rehab facility

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- having a confirmed diagnosis of COVID-19
- being mechanically ventilated for at least 24 hours
- surviving to critical care discharge.
Exclusion Criteria:
- none

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04396197
United Kingdom | |
UHB NHS Foundation Trust | |
Birmingham, United Kingdom, B15 2GW |
Responsible Party: | David McWilliams, Consultant Physiotherapist, University Hospital Birmingham NHS Foundation Trust |
ClinicalTrials.gov Identifier: | NCT04396197 |
Other Study ID Numbers: |
PhysioCOVID-19 |
First Posted: | May 20, 2020 Key Record Dates |
Last Update Posted: | May 20, 2020 |
Last Verified: | May 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
COVID-19 Critical Illness Respiratory Tract Infections Infections Pneumonia, Viral Pneumonia Virus Diseases Coronavirus Infections |
Coronaviridae Infections Nidovirales Infections RNA Virus Infections Lung Diseases Respiratory Tract Diseases Disease Attributes Pathologic Processes |